All the news Showing 10 of 39 articles from: Harm reduction interventions and policyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Ukraine: viral hepatitis and harm reduction services for refugees Keith Alcorn / 10 May 2022 The European Association for the Study of the Liver (EASL), the World Health Organization (WHO) and the European Centre for Disease Prevention and Control have issued a joint statement on viral hepatitis care ... UK report urges re-think on hepatitis C reinfection Keith Alcorn / 11 April 2022 Progress towards the elimination of hepatitis C is being undermined by a lack of attention to the harm reduction needs of people cured of hepatitis C in the United Kingdom, as ... Prioritise harm reduction services to prevent hepatitis C re-infection, Scottish study finds Keith Alcorn / 24 January 2022 Limiting re-infection with hepatitis C in people who use drugs is most likely to be achieved by intensifying provision of sterile injecting equipment for people using needle and syringe programmes and increasing ... Swiss opioid substitution therapy programme reports strong progress towards hepatitis C elimination Keith Alcorn / 14 April 2021 Direct-acting antiviral treatment cured almost everyone treated for hepatitis C in a large cohort of people receiving opioid substitution therapy, Swiss researchers report in the Swiss Medical Weekly. The study also observed a ... 12 good practices that should be part of the hepatitis C standard of care Keith Alcorn / 25 March 2021 Hepatitis C programmes and health services should review whether they are using best practices in diagnosis, treatment and care of people with hepatitis C, and update service models to improve hepatitis C elimination ... Bacterial infection of the heart on the rise among people with hepatitis C in United States Keith Alcorn / 23 June 2020 Diagnoses of infective endocarditis, a life-threatening bacterial infection of the heart valves, have become more common over the past ten years among people with hepatitis C and people with opioid use disorder ... Hepatitis C spreading through same networks and practices in HIV-positive and HIV-negative gay and bisexual men in England Keith Alcorn / 09 April 2020 Gay and bisexual men who acquire hepatitis C infection while using pre-exposure prophylaxis (PrEP) for HIV prevention are part of the same sexual networks and have the same risk factors as HIV-positive ... 90% of people who inject drugs in United States missed opportunities for HIV or hepatitis C tests Keith Alcorn / 27 February 2020 Around 90% of people who inject drugs in the United States missed opportunities for HIV or hepatitis C virus testing between 2010 and 2017, a review of more than 840,000 healthcare visits shows. ... Hepatitis C treatment and prevention failing to reach people most affected Keith Alcorn / 25 February 2020 Major gaps in harm reduction and treatment provision for people who inject drugs jeopardise the achievement of global targets for hepatitis C elimination by 2030, a review of hepatitis C treatment and ... Half of people who inject drugs in Middle East have hepatitis C Keith Alcorn / 24 February 2020 Half of people who inject drugs in the Middle East and north Africa have been infected with hepatitis C, and researchers from Weill Cornell Medicine Qatar estimate that around 221,000 people who ... ← First123...4Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive